Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 955

1.

Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer.

Nakagawa K, Hida T, Nokihara H, Morise M, Azuma K, Kim YH, Seto T, Takiguchi Y, Nishio M, Yoshioka H, Kumagai T, Hotta K, Watanabe S, Goto K, Satouchi M, Kozuki T, Koyama R, Mitsudomi T, Yamamoto N, Asakawa T, Hayashi M, Hasegawa W, Tamura T.

Lung Cancer. 2019 Nov 28;139:195-199. doi: 10.1016/j.lungcan.2019.11.025. [Epub ahead of print]

PMID:
31812890
2.

Association between metastatic sites and first-line pembrolizumab treatment outcome for advanced non-small cell lung cancer with high PD-L1 expression: a retrospective multicenter cohort study.

Kawachi H, Tamiya M, Tamiya A, Ishii S, Hirano K, Matsumoto H, Fukuda Y, Yokoyama T, Kominami R, Fujimoto D, Hosoya K, Suzuki H, Hirashima T, Kanazu M, Sawa N, Uchida J, Morita M, Makio T, Hara S, Kumagai T.

Invest New Drugs. 2019 Nov 30. doi: 10.1007/s10637-019-00882-5. [Epub ahead of print]

PMID:
31784866
3.

Comparison of oral microbiome profiles in stimulated and unstimulated saliva, tongue, and mouth-rinsed water.

Jo R, Nishimoto Y, Umezawa K, Yama K, Aita Y, Ichiba Y, Murakami S, Kakizawa Y, Kumagai T, Yamada T, Fukuda S.

Sci Rep. 2019 Nov 6;9(1):16124. doi: 10.1038/s41598-019-52445-6.

4.

Caregiving for older adults requiring hemodialysis: A comparison study.

Sugisawa H, Shinoda T, Shimizu Y, Kumagai T, Sugisaki H, Sugihara Y.

Ther Apher Dial. 2019 Nov 6. doi: 10.1111/1744-9987.13453. [Epub ahead of print]

PMID:
31693297
5.

Real-space observation of far- and near-field-induced photolysis of molecular oxygen on an Ag(110) surface by visible light.

Lin C, Ikeda K, Shiota Y, Yoshizawa K, Kumagai T.

J Chem Phys. 2019 Oct 14;151(14):144705. doi: 10.1063/1.5112158.

PMID:
31615227
6.

Disparity in pre-emptive end-of-life conversation experience caused by subjective economic status among general Japanese elderly people: a cross-sectional study with stratified random sampling.

Hidaka T, Endo S, Kasuga H, Masuishi Y, Kakamu T, Kumagai T, Saito K, Abe K, Fukushima T.

BMJ Open. 2019 Oct 7;9(10):e031681. doi: 10.1136/bmjopen-2019-031681.

7.

Glycolytic enzyme hexokinase II is a putative therapeutic target in B-cell malignant lymphoma.

Nakajima K, Kawashima I, Koshiisi M, Kumagai T, Suzuki M, Suzuki J, Mitsumori T, Kirito K.

Exp Hematol. 2019 Oct;78:46-55.e3. doi: 10.1016/j.exphem.2019.09.023. Epub 2019 Sep 24.

PMID:
31560931
8.

Extrinsic Upregulation of PD-L1 Induced by Pembrolizumab Combination Therapy in Patients with NSCLC with Low Tumor PD-L1 Expression.

Kunimasa K, Nakamura H, Nishino K, Nakatsuka SI, Kumagai T.

J Thorac Oncol. 2019 Oct;14(10):e231-e233. doi: 10.1016/j.jtho.2019.05.026. No abstract available.

PMID:
31558236
9.

Application of 2017 New Classification of Periodontal Disease and Condition to Localized Aggressive Periodontitis: Case Series.

Miyamoto T, Kumagai T, Khan S, Reddy M.

Clin Adv Periodontics. 2019 Jun 3. doi: 10.1002/cap.10068. [Epub ahead of print]

PMID:
31496127
10.

Efficacy and safety of pembrolizumab as first-line therapy in advanced non-small cell lung cancer with at least 50% PD-L1 positivity: a multicenter retrospective cohort study (HOPE-001).

Tamiya M, Tamiya A, Hosoya K, Taniguchi Y, Yokoyama T, Fukuda Y, Hirano K, Matsumoto H, Kominami R, Suzuki H, Hirashima T, Uchida J, Morita M, Kanazu M, Sawa N, Kinoshita Y, Hara S, Kumagai T, Fujimoto D.

Invest New Drugs. 2019 Dec;37(6):1266-1273. doi: 10.1007/s10637-019-00843-y. Epub 2019 Aug 7.

PMID:
31392549
11.

Endotracheal tube mucus as a source of airway mucus for rheological study.

Markovetz MR, Subramani DB, Kissner WJ, Morrison CB, Garbarine IC, Ghio A, Ramsey KA, Arora H, Kumar P, Nix DB, Kumagai T, Krunkosky TM, Krause DC, Radicioni G, Alexis NE, Kesimer M, Tiemeyer M, Boucher RC, Ehre C, Hill DB.

Am J Physiol Lung Cell Mol Physiol. 2019 Oct 1;317(4):L498-L509. doi: 10.1152/ajplung.00238.2019. Epub 2019 Aug 7.

PMID:
31389736
12.

Integrated genetic and epigenetic analysis revealed heterogeneity of acute lymphoblastic leukemia in Down syndrome.

Kubota Y, Uryu K, Ito T, Seki M, Kawai T, Isobe T, Kumagai T, Toki T, Yoshida K, Suzuki H, Kataoka K, Shiraishi Y, Chiba K, Tanaka H, Ohki K, Kiyokawa N, Kagawa J, Miyano S, Oka A, Hayashi Y, Ogawa S, Terui K, Sato A, Hata K, Ito E, Takita J.

Cancer Sci. 2019 Oct;110(10):3358-3367. doi: 10.1111/cas.14160. Epub 2019 Sep 10.

13.

Multicenter, placebo-controlled, double-blind, randomized study of fosnetupitant in combination with palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy.

Sugawara S, Inui N, Kanehara M, Morise M, Yoshimori K, Kumagai T, Fukui T, Minato K, Iwashima A, Takeda Y, Kubota K, Saeki T, Tamura T.

Cancer. 2019 Nov 15;125(22):4076-4083. doi: 10.1002/cncr.32429. Epub 2019 Aug 5.

PMID:
31381152
14.

Resolving the Correlation between Tip-Enhanced Resonance Raman Scattering and Local Electronic States with 1 nm Resolution.

Liu S, Müller M, Sun Y, Hamada I, Hammud A, Wolf M, Kumagai T.

Nano Lett. 2019 Aug 14;19(8):5725-5731. doi: 10.1021/acs.nanolett.9b02345. Epub 2019 Aug 5.

15.

Which Is Better EGFR-TKI Followed by Osimertinib: Afatinib or Gefitinib/Erlotinib?

Tamiya M, Tamiya A, Suzuki H, Moriizumi K, Nakahama K, Taniguchi Y, Kunimasa K, Kimura M, Inoue T, Kuhara H, Nishino K, Hirashima T, Atagi S, Imamura F, Kumagai T.

Anticancer Res. 2019 Jul;39(7):3923-3929. doi: 10.21873/anticanres.13544.

PMID:
31262922
16.

Molecular response of CSF3R T618I harboring chronic neutrophilic leukemia after induction chemotherapy linked to cord blood transplantation.

Kawashima I, Kumagai T, Suzuki M, Suzuki J, Koshiishi M, Nakajima K, Kirito K.

Ann Hematol. 2019 Sep;98(9):2249-2250. doi: 10.1007/s00277-019-03733-8. Epub 2019 Jun 25. No abstract available.

PMID:
31240470
17.

Production of recombinant extracellular cholesterol esterase using consistently active promoters in Burkholderia stabilis.

Yoshida K, Konishi K, Magana-Mora A, Rougny A, Yasutake Y, Muramatsu S, Murata S, Kumagai T, Aburatani S, Sakasegawa SI, Tamura T.

Biosci Biotechnol Biochem. 2019 Oct;83(10):1974-1984. doi: 10.1080/09168451.2019.1630256. Epub 2019 Jun 19.

PMID:
31216942
18.

Whole-Genome Sequence of Monascus purpureus GB-01, an Industrial Strain for Food Colorant Production.

Kumagai T, Tsukahara M, Katayama N, Yaoi K, Aburatani S, Ohdan K, Fujimori KE.

Microbiol Resour Announc. 2019 Jun 13;8(24). pii: e00196-19. doi: 10.1128/MRA.00196-19.

19.

Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for clinical microbiology in 2014: General view of the pathogens' antibacterial susceptibility.

Yanagihara K, Matsumoto T, Aoki N, Sato J, Wakamura T, Kiyota H, Tateda K, Hanaki H, Ohsaki Y, Fujiuchi S, Takahashi M, Akiba Y, Masunaga S, Takeuchi K, Takeda H, Miki M, Kumagai T, Takahashi H, Utagawa M, Nishiya H, Kawakami S, Ishigaki S, Kobayasi N, Takasaki J, Mezaki K, Iwata S, Katouno Y, Inose R, Niki Y, Kawana A, Fujikura Y, Kudo M, Hirano T, Yamamoto M, Miyazawa N, Tsukada H, Aso S, Yamamoto Y, Iinuma Y, Mikamo H, Yamagishi Y, Nakamura A, Ohashi M, Kawabata A, Sugaki Y, Seki M, Hamaguchi S, Toyokawa M, Kakeya H, Fujikawa Y, Mitsuno N, Ukimura A, Miyara T, Hayasi M, Mikasa K, Kasahara K, Koizumi A, Korohasi N, Matumoto T, Yosimura Y, Katanami Y, Takesue Y, Wada Y, Sugimoto K, Yamamoto T, Kuwabara M, Doi M, Simizu S, Tokuyasu H, Hino S, Negayama K, Mukae H, Kawanami T, Yatera K, Fujita M, Kadota J, Hiramatsu K, Aoki Y, Magarifuchi H, Oho M, Morinaga Y, Suga M, Muranaka H, Fujita J, Higa F, Tateyama M.

J Infect Chemother. 2019 Sep;25(9):657-668. doi: 10.1016/j.jiac.2019.05.006. Epub 2019 Jun 10.

PMID:
31196772
20.

Electroretinograms before and after extraction of large intraocular iron foreign body.

Kumagai T, Matsumoto CS, Kimura I, Shinoda K.

Am J Ophthalmol Case Rep. 2019 May 9;15:100463. doi: 10.1016/j.ajoc.2019.100463. eCollection 2019 Sep.

21.

Developing a codon optimization method for improved expression of recombinant proteins in actinobacteria.

Saito Y, Kitagawa W, Kumagai T, Tajima N, Nishimiya Y, Tamano K, Yasutake Y, Tamura T, Kameda T.

Sci Rep. 2019 Jun 6;9(1):8338. doi: 10.1038/s41598-019-44500-z.

22.

Nutritional risk index as a risk factor for breakthrough candidemia in allogeneic hematopoietic stem cell transplantation.

Kaito S, Sekiya N, Najima Y, Suzuki T, Wada A, Adachi H, Konuma R, Kishida Y, Nagata A, Konishi T, Yamada Y, Kumagai T, Inamoto K, Yoshifuji K, Akiyama M, Toya T, Igarashi A, Muto H, Doki N, Kobayashi T, Kakihana K, Ohashi K.

Bone Marrow Transplant. 2019 May 29. doi: 10.1038/s41409-019-0541-1. [Epub ahead of print] No abstract available.

PMID:
31142797
23.

Psychosocial Mediators between Socioeconomic Status and Dietary Restrictions among Patients Receiving Hemodialysis in Japan.

Sugisawa H, Shinoda T, Shimizu Y, Kumagai T, Sugisaki H.

Int J Nephrol. 2019 Apr 17;2019:7647356. doi: 10.1155/2019/7647356. eCollection 2019.

24.

Bone Marrow Invasion of Small Cell Neuroendocrine Carcinoma of the Endometrium: A Diagnostic Pitfall Mimicking a Haematological Malignancy.

Kawashima I, Fukasawa H, Kasai K, Kumagai T, Koshiishi M, Nakajima K, Kondo T, Hashi A, Hirata S, Kirito K.

Intern Med. 2019 Sep 1;58(17):2561-2568. doi: 10.2169/internalmedicine.2533-18. Epub 2019 May 22.

25.

Patients with SMARCA4-deficient thoracic sarcoma and severe skeletal-related events.

Kunimasa K, Nakamura H, Sakai K, Tamiya M, Kimura M, Inoue T, Nishino K, Kuhara H, Nakatsuka SI, Nishio K, Imamura F, Kumagai T.

Lung Cancer. 2019 Jun;132:59-64. doi: 10.1016/j.lungcan.2019.03.029. Epub 2019 Apr 8.

PMID:
31097095
26.

Associations of presence or absence of exercise and/or physical activity with non-restorative sleep by gender and age: a cross-sectional study.

Hidaka T, Endo S, Kasuga H, Masuishi Y, Kakamu T, Kumagai T, Fukushima T.

BMJ Open. 2019 May 10;9(5):e025730. doi: 10.1136/bmjopen-2018-025730.

27.

Near-Field Manipulation in a Scanning Tunneling Microscope Junction with Plasmonic Fabry-Pérot Tips.

Böckmann H, Liu S, Müller M, Hammud A, Wolf M, Kumagai T.

Nano Lett. 2019 Jun 12;19(6):3597-3602. doi: 10.1021/acs.nanolett.9b00558. Epub 2019 May 15.

28.

Factors associated with possession of accurate knowledge regarding occupational health management among operations leaders of radiation decontamination workers in Fukushima, Japan: a cross-sectional study.

Hidaka T, Kakamu T, Endo S, Kasuga H, Masuishi Y, Kumagai T, Sato S, Sasaki T, Fukushima T.

BMJ Open. 2019 May 5;9(5):e025729. doi: 10.1136/bmjopen-2018-025729.

29.

Is an immune checkpoint inhibitor really a hopeless therapeutic choice for EGFR-mutant non-small cell lung cancer (NSCLC) patients?

Kunimasa K, Nishino K, Kumagai T.

Ann Transl Med. 2019 Mar;7(Suppl 1):S32. doi: 10.21037/atm.2019.02.18. No abstract available.

30.

Feasibility of Smart Metal Artifact Reduction Algorithm on Computed Tomography Angiography for Clipping of Recurrent Aneurysms After Coil Embolization.

Kuroda H, Toyota S, Kumagai T, Iwata T, Kobayashi M, Mori K, Taki T.

World Neurosurg. 2019 Jul;127:e1249-e1254. doi: 10.1016/j.wneu.2019.04.133. Epub 2019 Apr 23.

PMID:
31026660
31.

Characteristics of awareness and behavior of medical staff for prevention of falling accidents among inpatients.

Kinoshita M, Takeda H, Yamada C, Kumagai T, Kakamu T, Hidaka T, Masuishi Y, Endo S, Hashimoto S, Fukushima T.

Fukushima J Med Sci. 2019;65(1):13-23. doi: 10.5387/fms.2018-22.

32.

Successful hematopoietic stem-cell mobilization with plerixafor plus granulocyte-colony stimulating factor in multiple myeloma patients treated with pomalidomide.

Yoshifuji K, Toya T, Adachi H, Fujita M, Wada A, Konuma R, Kishida Y, Konishi T, Nagata A, Yamada Y, Kaito S, Kumagai T, Inamoto K, Akiyama M, Igarashi A, Najima Y, Doki N, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K.

Int J Hematol. 2019 Jul;110(1):115-118. doi: 10.1007/s12185-019-02622-0. Epub 2019 Apr 13.

PMID:
30989487
33.

Unhealthy changes in eating habits cause acute onset hypertension in the normotensive community-dwelling elderly-3 years cohort study.

Kakamu T, Hidaka T, Kumagai T, Masuishi Y, Kasuga H, Endo S, Sato S, Takeda A, Koizumi M, Fukushima T.

Medicine (Baltimore). 2019 Apr;98(15):e15071. doi: 10.1097/MD.0000000000015071.

34.

Electrochemical fabrication of fibrin gels via cascade reaction for cell culture.

Taira N, Ino K, Kumagai T, Nashimoto Y, Shiku H.

Chem Commun (Camb). 2019 May 10;55(37):5335-5338. doi: 10.1039/c9cc01576k. Epub 2019 Apr 10.

PMID:
30968103
35.

Near-Field Spectral Response of Optically Excited Scanning Tunneling Microscope Junctions Probed by Single-Molecule Action Spectroscopy.

Böckmann H, Müller M, Hammud A, Willinger MG, Pszona M, Waluk J, Wolf M, Kumagai T.

J Phys Chem Lett. 2019 May 2;10(9):2068-2074. doi: 10.1021/acs.jpclett.9b00822. Epub 2019 Apr 15.

36.

Serum IgM Glycosylation Associated with Tuberculosis Infection in Mice.

Kumagai T, Palacios A, Casadevall A, García MJ, Toro C, Tiemeyer M, Prados-Rosales R.

mSphere. 2019 Mar 27;4(2). pii: e00684-18. doi: 10.1128/mSphere.00684-18.

37.

Comprehensive analysis of resistance-nodulation-cell division superfamily (RND) efflux pumps from Serratia marcescens, Db10.

Toba S, Minato Y, Kondo Y, Hoshikawa K, Minagawa S, Komaki S, Kumagai T, Matoba Y, Morita D, Ogawa W, Gotoh N, Tsuchiya T, Kuroda T.

Sci Rep. 2019 Mar 19;9(1):4854. doi: 10.1038/s41598-019-41237-7.

38.

Characteristics of anxiety and the factors associated with presence or absence of each anxiety among radiation decontamination workers in Fukushima.

Kakamu T, Hidaka T, Kumagai T, Jinnouchi T, Sato S, Masuishi Y, Endo S, Nakano S, Koyama K, Fukushima T.

Ind Health. 2019 Sep 26;57(5):580-587. doi: 10.2486/indhealth.2018-0094. Epub 2019 Feb 22.

39.

Dasatinib for chronic myelogenous leukemia improves skin symptoms of systemic sclerosis.

Arai K, Yoshifuji K, Motomura Y, Sonokawa S, Suzuki S, Kumagai T.

Int J Hematol. 2019 Jun;109(6):718-722. doi: 10.1007/s12185-019-02618-w. Epub 2019 Feb 20.

PMID:
30788724
40.

Phosphate binding by sucroferric oxyhydroxide ameliorates renal injury in the remnant kidney model.

Nemoto Y, Kumagai T, Ishizawa K, Miura Y, Shiraishi T, Morimoto C, Sakai K, Omizo H, Yamazaki O, Tamura Y, Fujigaki Y, Kawachi H, Kuro-O M, Uchida S, Shibata S.

Sci Rep. 2019 Feb 11;9(1):1732. doi: 10.1038/s41598-018-38389-3.

41.

A case of Niemann-Pick disease type C with neonatal liver failure initially diagnosed as neonatal hemochromatosis.

Kumagai T, Terashima H, Uchida H, Fukuda A, Kasahara M, Kosuga M, Okuyama T, Tsunoda T, Inui A, Fujisawa T, Narita A, Eto Y, Kubota M.

Brain Dev. 2019 May;41(5):460-464. doi: 10.1016/j.braindev.2019.01.004. Epub 2019 Feb 6.

42.

Efficacy and Safety of a Weekly Cyclophosphamide-Bortezomib-Dexamethasone Regimen as Induction Therapy Prior to Autologous Stem Cell Transplantation in Japanese Patients with Newly Diagnosed Multiple Myeloma: A Phase 2 Multicenter Trial.

Tanaka K, Toyota S, Akiyama M, Wakimoto N, Nakamura Y, Najima Y, Doki N, Kakihana K, Igarashi A, Kobayashi T, Ohashi K, Kudo D, Shinagawa A, Takano H, Fujio T, Okoshi Y, Hori M, Kumagai T, Saito T, Mukae J, Yamamoto K, Tsutsumi I, Komeno T, Yoshida C, Yamamoto M, Kojima H; on behalf of the Ochanomizu Hematology Study Group.

Acta Haematol. 2019;141(2):111-118. doi: 10.1159/000495338. Epub 2019 Feb 6.

PMID:
30726834
43.

[Chronic myeloid leukemia harboring T315I and F317L mutations successfully treated with interferon-α and ponatinib].

Motomura Y, Arai K, Yoshifuji K, Sonokawa S, Suzuki S, Kumagai T.

Rinsho Ketsueki. 2019;60(1):33-38. doi: 10.11406/rinketsu.60.33. Japanese.

PMID:
30726822
44.

Real-Space Observation of Quantum Tunneling by a Carbon Atom: Flipping Reaction of Formaldehyde on Cu(110).

Lin C, Durant E, Persson M, Rossi M, Kumagai T.

J Phys Chem Lett. 2019 Feb 7;10(3):645-649. doi: 10.1021/acs.jpclett.8b03806. Epub 2019 Jan 29.

45.

Elucidating the Nuclear Quantum Dynamics of Intramolecular Double Hydrogen Transfer in Porphycene.

Litman Y, Richardson JO, Kumagai T, Rossi M.

J Am Chem Soc. 2019 Feb 13;141(6):2526-2534. doi: 10.1021/jacs.8b12471. Epub 2019 Feb 1.

46.

Successful Treatment for Refractory Interstitial Lung Disease and Pneumomediastinum With Multidisciplinary Therapy Including Tofacitinib in a Patient With Anti-MDA5 Antibody-Positive Dermatomyositis.

Kato M, Ikeda K, Kageyama T, Kasuya T, Kumagai T, Furuya H, Furuta S, Tamachi T, Suto A, Suzuki K, Nakajima H.

J Clin Rheumatol. 2019 Jan 4. doi: 10.1097/RHU.0000000000000984. [Epub ahead of print] No abstract available.

PMID:
30614890
47.

International symposium defines the future role of oral physicians.

Nishi M, Wilson N, Nishino M, Phantumvanit P, Songpaisan Y, Na Songkhla M, Kumagai T.

Oral Dis. 2019 Mar;25(2):634-635. doi: 10.1111/odi.13025. Epub 2019 Jan 11. No abstract available.

PMID:
30580465
48.

Semaphorin 7A promotes EGFR-TKI resistance in EGFR mutant lung adenocarcinoma cells.

Kinehara Y, Nagatomo I, Koyama S, Ito D, Nojima S, Kurebayashi R, Nakanishi Y, Suga Y, Nishijima-Futami Y, Osa A, Nakatani T, Kato Y, Nishide M, Hayama Y, Higashiguchi M, Morimura O, Miyake K, Kang S, Minami T, Hirata H, Iwahori K, Takimoto T, Takamatsu H, Takeda Y, Hosen N, Hoshino S, Shintani Y, Okumura M, Kumagai T, Nishino K, Imamura F, Nakatsuka SI, Kijima T, Kida H, Kumanogoh A.

JCI Insight. 2018 Dec 20;3(24). pii: 123093. doi: 10.1172/jci.insight.123093.

49.

Plasmon-Assisted Resonant Electron Tunneling in a Scanning Tunneling Microscope Junction.

Liu S, Wolf M, Kumagai T.

Phys Rev Lett. 2018 Nov 30;121(22):226802. doi: 10.1103/PhysRevLett.121.226802.

PMID:
30547648
50.

Asunaprevir and daclatasvir in hemodialysis patients with chronic hepatitis C virus genotype 1b infection.

Otsuka T, Kawaguchi Y, Mizuta T, Ide Y, Koga F, Kumagai T, Yoshioka W, Murayama K, Rikitake O, Ikeda Y, Ozaki I.

JGH Open. 2017 Nov 28;1(4):148-152. doi: 10.1002/jgh3.12026. eCollection 2017 Dec.

Supplemental Content

Loading ...
Support Center